Dr Berni Sewell
Senior Lecturer
College of Human and Health Sciences
Telephone: (01792) 602117
Room: SCHE
Second Floor
Vivian Building
Singleton Campus

Berni has been working in biomedical research since 2004 and started employment at Swansea University as a health economist in 2009. Since then she has been involved in over 20 projects as Principal Investigator or lead health economist with collaborators across the UK and Europe.

 Her main focus of work in recent years has been on cancer treatment, nosocomial infections, chronic pain and health technology assessment.

Recently completed work includes leading the health economic modelling undertaken to estimate the cost-effectiveness of stem cell transplantation and to inform guidance as recently published in NICE guidance NG52 (management of non-Hodgkin’s Lymphoma); lead health economist in modelling cost-effectiveness of new interventions in the treatment of chronic pain and lead health economist in the analysis of cost-effectiveness of a risk scoring tool in primary care.

Berni is the SCHE team leader for the health economic assessment of new medicines submitted to the All Wales Therapeutic and Toxicology Centre (AWTTC) as part of the review undertaken by the New Medicines Group and All Wales Medicines Strategy Group (AWMSG).

Areas of Expertise

  • health economics
  • cost-effectivness
  • economic modelling
  • health technology assessment


  1. et. al. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Trials 18(1)
  2. & TIMELY SOCIAL CARE AND EMERGENCY HOSPITAL ADMISSIONS. Emergency Medicine Journal 33(9), 678-678.
  3. & Cost and Impact on Patient Length of Stay of Rapid Molecular Testing for Clostridium difficile. Infectious Diseases and Therapy 3(2), 281-293.
  4. & Real-time polymerase chain reaction correlates well with clinical diagnosis of Clostridium difficile infection. Journal of Hospital Infection 87(2), 109-114.
  5. & A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technology Assessment 17(57)

See more...


  • Opioid prescribing in Wales (current)

    Student name:
    Other supervisor: Prof Jaynie Rance
    Other supervisor: Dr Berni Sewell
    Other supervisor: Prof Ceri Phillips